Clinical Trials Logo

Clinical Trial Summary

In this feasibility study, we aim to explore therapeutic Rheopheresis (RheoP) as a novel treatment option for SSc-associated Raynaud's phenomenon and/or digital ulcers and compare it to the standard of care treatment (intravenous iloprost. RheoP has been used for RP/DU with some success in observational studies, nevertheless, the optimal treatment modality, duration, or frequency of RheoP (and PEX in general) in SSc has not been established as of yet.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05204784
Study type Interventional
Source University of Göttingen
Contact Peter Korsten, Dr. med.
Phone +49-551-39-60400
Email [email protected]
Status Recruiting
Phase N/A
Start date February 28, 2022
Completion date June 2024

See also
  Status Clinical Trial Phase
Completed NCT03274076 - Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc) Phase 1/Phase 2
Recruiting NCT04300426 - Safety and Efficacy of Anaerobic Cultivated Human Intestinal Microbiome Transplantation in Systemic Sclerosis (ReSScue) Phase 2
Recruiting NCT04356755 - Subcutaneous Injections of Autologous ASC to Heal Digital Ulcers in Patients With Scleroderma. Phase 2
Recruiting NCT02551042 - CSL Behring Sclero XIII Phase 2
Terminated NCT02243111 - Detecting Pulmonary Arterial Hypertension (PAH) in Patients With Systemic Sclerosis (SSc) by Ultrasound N/A
Terminated NCT02246348 - Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc) N/A
Completed NCT01933334 - Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Phase 2
Completed NCT01468792 - Hemodynamic Changes in Connective Tissue Disease N/A
Terminated NCT00848107 - Open-Label Study of Oral Treprostinil in Digital Ulcers Phase 2
Completed NCT00984932 - Effect of Rosuvastatin on Systemic Sclerosis-related Pulmonary Hypertension Phase 3
Recruiting NCT00074568 - Scleroderma Registry
Terminated NCT00622687 - Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis Phase 2
Recruiting NCT04464434 - Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis Phase 3
Recruiting NCT04246528 - SPIN Self-Management Feasibility Trial With Progression to Full-scale Trial (SPIN-SELF) N/A
Completed NCT03678987 - Mycophenolate Mofetil Pharmacokinetics in Systemic Sclerosis
Recruiting NCT05234671 - Exercise in People With Systemic Sclerosis N/A
Recruiting NCT04132206 - Longitudinal Characterization of Microbial Signature in Systemic Sclerosis Patients
Recruiting NCT03211793 - Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis Phase 1/Phase 2
Recruiting NCT03374618 - Neutrophil Extracellular Traps in Systemic Sclerosis N/A
Active, not recruiting NCT04368403 - A Study of KHK4827 in Patients With Systemic Sclerosis Phase 1